Clinical Trial Update: Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ultra-hypofractionated versus standard hypofractionated radiation therapy for node-positive breast cancer is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Node-positive Breast Cancer | Phase 2 | Status: RECRUITING